Semax and Modulation of Melanocortin Pathways: Evidence in Neuroprotection, BDNF, and Cognitive Plasticity (2025)

Abstract

Semax is a heptapeptide derived from ACTH(4-7), modified to potentiate neuromodulatory effects without peripheral adrenal activation. Studies published between 1990 and 2024 show that Semax increases BDNF expression, modulates melanocortin pathways, confers neuroprotection against hypoxia/ischaemia and improves attention, memory and cognitive processing parameters. This review compiles clinical and pre-clinical evidence, organising the central biological mechanisms and experimental results.

1. introduction

Semax was developed at the Russian Biomedical Research Institute as:

• Neuroprotective agent
• Cognitive modulator
• Neuroendocrine stress regulator

It is derived from the ACTH(4-7) fragment with a Pro-Gly-Pro modification that increases stability and prolongs central action.

Unlike full ACTH:

• No stimulates cortisol
• No activates HPA axis systemically
• Acts predominantly at the neurological level

Used experimentally in:

• Cognitive deficits
• Recovery after hypoxia/ischaemia
• Increased executive attention
• States of stress
• Neural plasticity

2. Fundamental Biological Mechanisms

2.1 Melanocortin pathway (MC4R and MC5R)

Semax interacts with:

• Melanocortin MC4R receptors
• Melanocortin MC5R receptors

Effects:

• Increased controlled neuronal excitability
• Regulation of the glutamate/GABA balance
• Modulation of the stress response

The melanocortin pathway is critical for:

• Cognition
• Humour
• Neuroplasticity
• Autonomic homeostasis

2.2 Upregulation of BDNF (the most consistent effect)

BDNF (Brain-Derived Neurotrophic Factor):

• Supports neuronal growth and survival
• Modulates synapse formation
• Increases learning and memory consolidation

Studies show:

• ↑ BDNF in the prefrontal cortex
• ↑ BDNF in the hippocampus
• ↑ NGF expression in some models

These effects occur even with short-term administration.

2.3 Synaptic plasticity

Semax activates multiple routes:

• ERK
• CREB
• PI3K
• mTOR (mild and dose-dependent)

Consequences:

• Working memory enhancement
• Improvement in spatial learning
• Increased synaptogenesis
• Post-stress recovery

2.4 Neuroprotection against hypoxia and ischaemia

Semax has been shown to protect neurons in models of:

• Interruption of blood flow
• Hypoxic encephalopathy
• Oxidative stress
• Induced inflammation

The mechanisms include:

• Reduction of ROS
• Increase in antioxidant enzymes
• Glutamate regulation
• Inhibition of early apoptosis

2.5 Regulation of the stress response

Semax:

• Reduces the impact of hyperactivation of the HPA axis
• Can normalise levels of induced anxiety
• Improves sustained attention in stressful environments

Observational studies show improved cognitive performance under pressure.

3. Pre-clinical and clinical evidence

3.1 Cognitive studies

Improvements observed in:

• Processing speed
• Executive attention
• Working memory
• Performance in complex visual tasks
• Acute post-stress states

3.2 Brain injury studies

Models of ischaemia have demonstrated:

• Reduction of neuronal loss
• Accelerated functional recovery
• Reduction of glial inflammation

3.3 Studies in old age

Benefits:

• Improved episodic memory
• Increased motivation and mental energy
• Reduction of cognitive slowing

Effects attributed to increased BDNF + synaptic improvement.

4. Bioavailability and Pharmacodynamics

• Typical administration under investigation: intranasal
• Absorption through the lamina cribiforme
• Fast central action
• Half-life: estimated 12-20 minutes
• Prolonged effects via signalling cascades

Even with a short half-life, it influences hours of plasticity.

5. Research applications

5.1 Cognition and intellectual performance

Areas where Semax has shown efficacy:

• Accelerated learning
• Sustained attention tasks
• High cognitive load
• Execution under stress

5.2 Neuroprotection

Studies suggest that Semax:

• Reduces apoptosis
• Protects against hypoperfusion
• Improves motor recovery
• Stabilises reactive microglia

5.3 Mental health and anxiety

Comments:

• Reduction of mild to moderate anxiety
• Improvement in mood in stressful situations
• Increased ability to focus

6. Safety, Side Effects and Contraindications

Generally well tolerated

Described effects:

• Mild nasal irritation
• Mild headache
• Excessive mental stimulation in high doses
• Insomnia if used too late

Theoretical contraindications

• Epilepsy (due to increased excitability)
• Psychotic or manic states
• Pregnancy/lactation (no data)
• Unsupervised severe anxiety disorders

7. Conclusion

Semax is one of the most thoroughly studied compounds in the field of peptide neuromodulation. The evidence indicates robust effects on:

• BDNF
• Synaptic plasticity
• Neuroprotection
• Cognitive function
• Resistance to stress

Although large-scale Western research is lacking, the results of the last 30 years show a promising profile for exploratory studies in applied neuroscience.